Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Provenge Poised For Broad Insurance Coverage, Despite Grumbles On Price

Executive Summary

After a strong endorsement in the National Comprehensive Cancer Network guidelines, Dendreon's first-of-its-kind prostate cancer vaccine Provenge appears well positioned for broad insurance coverage and take-up with physicians
Advertisement

Related Content

Under Sanpower, Can Provenge Finally Have A Happy Ending?
Pfizer’s Xalkori Joins The Six-Figure Oncology Drug Club
Pfizer’s Xalkori Joins The Six-Figure Oncology Drug Club
As Yervoy Launch Nears, Pricing Of Maintenance Therapy Remains A Key Question
With Jevtana Approved For Advanced Prostate Cancer, Sanofi Could See Expansion To First-Line Use
Provenge Panel's Uncertainty Was More Persuasive To FDA Than Its Vote
Dendreon Readies For Next Provenge Hurdles: Supply And Reimbursement
Dendreon Readies For Next Provenge Hurdles: Supply And Reimbursement
What Payers Want: Reliable Data
Progression-Free Survival Represents Clinical Benefit, But How Much? – ODAC

Topics

Advertisement
UsernamePublicRestriction

Register

PS052262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel